Neurotolerability of nonionic x-ray contrast media: The role of chemotoxicity

Investigative Radiology

Volumn 31, Issue 6, 1996, Pages 338-344

  Luzzani, Franco ^a   Morisetti, Alberto ^a   Bussi, Simona ^a   Tirone, Piero ^a   De Haën, Christoph ^a  

^a Bracco SpA   (Italy)

Author keywords

chemotoxicity; Contrast media; intrathecal administration; neurotolerability; physicochemical properties

Indexed keywords

DIMERIC NONIONIC CONTRAST MEDIUM; HYPERTONIC SOLUTION; HYPOTONIC SOLUTION; IODINE; IODIXANOL; IOFRATOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPENTOL; IOPROMIDE; IOTROLAN; IOVERSOL; ISOTONIC SOLUTION; MANNITOL; MONOMERIC NONIONIC CONTRAST MEDIUM; NONIONIC CONTRAST MEDIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DEATH; DRUG FORMULATION; DYSPNEA; HYDROPHILICITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRACISTERNAL DRUG ADMINISTRATION; LETHAL DOSE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; X RAY;

EID: 0029882642     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199606000-00005     Document Type: Article

References (34)

1. La Noce A, Demicheli F, Filatori I, Miragoli L, Tirone P. Iomeprol: A neuropharmacological profile. Neuroradiology 1995; 37(suppl):545-547.
2. Schmiedl UP, Kenney J, Maravilla KR. Kinetics of pathologic blood-brain barrier permeability in an astrocytic glioma using contrast-enhanced MR. AJNR Am J Neuroradiol 1992;13:5-14.
3. Larsson H, Stubgaard M, Fredriksen J, Jensen M, Henriksen O, Paulson O. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16: 117-131.
4. O'Brien MD, Jordan MM, Waltz AG. Ischemic cerebral edema and the blood brain barrier: Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery. Arch Neurol 1974;30:461-465.
5. Harper CG. Wernicke's encephalopathy: A more common disease than realised. J Neurol Neurosurg Psychiatry 1979;47:426-441.
6. Bradley WG, Yuh WTC, Bydder GM. Use of MR imaging contrast agents in the brain. J Magn Reson Imaging 1993;3:199-218.
7. Betz LA, Goldstein GW, Katzman R. Blood-brain cerebrospinal fluid barriers. In: Siegel G, Agranoff B, Albers RW, Molinoff P, eds. Basic neurochemistry. New York, NY: Raven Press; 1989.
8. Sage MR. Kinetics of water-soluble contrast media in the central nervous system. AJNR Am J Neuroradiol 1983;4:897-906.
9. Adams MD, Ralston WH, Miller JW, Ferrendelli JA. Electroencephalographic effects of intracisternally injected nonionic x-ray contrast media in rats. Invest Radiol 1990;25:S86-S87.
10. Press WR, Mützel W, Schöbel C. Tolerance of iotrolan after subarachnoid injection in animals. In: Taenzer V, Wende S, eds. Recent developments in nonionic contrast media. Stuttgart: Thieme Verlag; 1989.
11. Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Ann Neurol 1983;13:469-484.
12. Wible JH Jr, Barco SJ, Scherrer DE, Wojdyla JK, Adams MD. Neurotoxicity of non-ionic x-ray contrast media after intracisternal administration in rats. Eur J Radiol 1995;19:206-211.
13. Spinazzi A, Davies A, Tirone P, Rosati G. Predictable and unpredictable adverse reactions to uroangiographic contrast media. Acad Radiol. In press.
14. Caillé JM, Allard M. Neurotoxicity of hydrosoluble iodine contrast media. Invest Radiol 1988;23(suppl 1):S210-S212.
15. Bonnemain B, Meyer D, Schaefer M, Dugast-Zrihen M, Legreneur S, Doucet D. New iodinated, low-osmolar contrast media: A revised concept of hydrophilicity. Invest Radiol 1990;25:S104-S106.
16. Adams MD, Ralston WH, Miller JW, Ferrendelli JA. Hydrophilicity and neurotoxicity of nonionic x-ray contrast media. In: Katayama H, Brasch RC, eds. New dimensions of contrast media. Excerpta Medica, Int Congress Series 976;1991:17-23.
17. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 1957;12:12-15.
18. Jeffers WA, Griffith JQ, eds. The rat in laboratory investigation. Philadelphia, PA: J.B. Lippincott Co.; 1949:196-197.
19. Merlis JK. The effects of changes in the calcium content of the cerebrospinal reflex activity in the dog. Am J Physiol 1940;131: 67-72.
20. Finney DJ. Statistical method in biological assay. Third ed. London: Griffin; 1978.
21. SAS/STAT user's guide. Release 6.03 ed. Cary, NC: SAS Institute Inc., 1988.
22. STATGRAPHICS user's guide. Release 2.6. Rockville, MA: STSC Inc., 1987.
23. Hoppe JO. Some pharmacological aspects of radiopaque compounds. Ann NY Acad Sci 1959;78:727-739.
24. Rosati G, Morisetti A, Tirone P. Toxicity in animals and safety in humans: The predictive value of animal studies. Toxicol Lett 1992;64/65:705-715.
25. Rosati G, Leto di Priolo S, Tirone P. Serious or fatal complications after unadvertent administration of ionic water-soluble contrast media in myelography. Eur J Radiol 1992;15:95-100.
26. Sovak M. Basic methods of investigative neuroradiology. In: Sovak M, ed. Radiocontrast agents. Berlin: Springer, 1984.
27. Gonsette RE, Brucher JM. Neurotoxicity of novel water-soluble contrast media for intrathecal application. Invest Radiol 1980;15:5254-5259.
28. Sovak M, Ranganathan R, Kerber CW, Bickford R, Alksne JF. Iotrol, a new myelographic agent. II: Comparative electroencephalographic evaluation by spectrum analysis. AJNR Am J Neuroradiol 1983;4:319-322.
29. Speck U, Mützel W, Mannesmann G, Pfeiffer H, Siefert H-M. Pharmacology of nonionic dimers. Invest Radiol 1980;15: S317-S322.
30. La Noce A, Bertani F, Lorusso V, Luzzani F, Tirone P, de Haën C. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. Eur J Radiol 1994;18(suppl 1): S43-S50.
31. La Noce A, Danieli A, Bertani F, Tirone P, de Haën C. Conditioned taste aversion in rats following intrathecal administration of contrast media. Acta Radiologica 1996;37:116-120.
32. Gallotti A, Uggeri F, Favilla A, Cabrini M, de Haën C. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur J Radiol 1994:18(suppl 1):S1-S12.
33. Skinnemoen K. Physicochemical properties and degree of protein binding of iopentol. Acta Radiologica 1987;(suppl 370):33-36.
34. Krause W, Miklautz H, Kollenkirchen U, Heimann G. Physicochemical parameters of x-ray contrast media. Invest Radiol 1994;29:72-80.